Creso Pharma Limited (ASX:CPH) announced last week it intends acquiring Colorado based natural body care company, Sierra Sage Herbs, LLC.Creso says the acquisition will provide it a foothold in the USA's CBD market through SSH's existing 90,000 points of sale with major retailers and more than 150,000 direct to...

Mississippi's Medical Cannabis Act is now law after Governor Tate Reeves added his signature - albeit grudgingly.Governor Reeves had five days from the day the bill landed on his desk on the 27th to either veto it, sign it or let it pass without his signature. He chose to...

A local council in the Australian state of New South Wales is supporting a hemp cultivation trial and processing feasibility study.The Murray River Council is a local government area in the Riverina region of New South Wales; formed in 2016 after the merger of Murray Shire with Wakool Shire.Council...

The USA's National Football League has announced recipients of grant funding to support research on the effects of cannabinoids on pain management and neuroprotection in athletes. But NFL players won't be participating.In June last year, the NFL and the NFL Players Association announced they were putting up $1 million...

The potential for a couple of hemp derived compounds to help in the COVID battle could be put to the test in the near future.Last month we reported on research out of Oregon State University research indicating certain hemp compounds (cannabigerolic acid - CBGA - and cannabidiolic acid -CBDA)...

Data from a UK registry collating outcomes on prescribed medical cannabis use indicates a statistically significant improvement in health-related quality of life for patients.The UK Medical Cannabis Registry, set up by Sapphire Medical, contains the details of what is reportedly the largest group of patients in the UK treated...

The Mississippi Legislature's approval of a medical cannabis bill means it now goes to Governor Tate Reeves. Whether he'll sign off on it is another matter.Before he was elected as Governor, Reeves expressed that he was against legalizing medical cannabis access, but indicated he wouldn't officially oppose it if...

Bod Australia has announced its planned phase IIB clinical trial of a cannabis extract with insomnia patients has received ethics approval.The trial will investigate the efficacy of a new prospective Schedule 3 CBD (cannabidiol) formulation on insomnia symptoms.In December 2020, Australia’s Therapeutic Goods Administration (TGA) gave the nod...

Canadian-headquartered Tilray Brands, Inc. says it is expanding its medical cannabis product offerings for patients and related education for health professionals in Australia.Accessible via Australia's Therapeutic Goods Administration (TGA) Special Access Scheme and Authorized Prescriber Scheme (where individual applications are approved), whole flower options including 1:1  (THC 10 CBD...

The New York State Office of Cannabis Management (OCM)  has expanded eligibility criteria for patients who could potentially benefit from medical cannabis.Changes announced on Monday that include certification and registration systems moving under the full control of the OCM allow the certification of a patient by a practitioner for...